Beyond Seizures as an Outcome Measure: A Global Severity Scoring System for CDKL5 Deficiency Disorder

The resultant global severity score provided evidence that the assessments formed a coherent set of measures that reliably and meaningfully captured the diversity of severity in CDD. The models illustrated how the symptoms form a measurable network of relationships which may be suitable as an outcome measure for CDD and DEEs more broadly in clinical trials.

Authors

Institutions

Publication Details

Journal
Brain and Behavior
Published
2025-11-01
DOI
https://doi.org/10.1002/brb3.71061
Primary Topic
Genetics and Neurodevelopmental Disorders
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Beyond Seizures as an Outcome Measure: A Global Severity Scoring System for CDKL5 Deficiency Disorder

Joni N. Saby, Tim A. Benke, R. Rajaraman, Heather E. Olson et al.
Brain and Behavior
Genetics and Neurodevelopmental Disorders
article

Beyond Seizures as an Outcome Measure: A Global Severity Scoring System for CDKL5 Deficiency Disorder

Joni N. Saby, Tim A. Benke, R. Rajaraman, Heather E. Olson, Jenny Downs, Elia Pestana‐Knight, Eric D. Marsh, Helen Leonard, Jacinta Saldaris, Scott Demarest, Judith Weisenberg, Peter Jacoby, Bernhard Suter, Dana Price
article en

Abstract

The resultant global severity score provided evidence that the assessments formed a coherent set of measures that reliably and meaningfully captured the diversity of severity in CDD. The models illustrated how the symptoms form a measurable network of relationships which may be suitable as an outcome measure for CDD and DEEs more broadly in clinical trials.

Brain and BehaviorVol. 15(11)
Boston Children's Hospital (US), Cleveland Clinic (US), St. Louis Children's Hospital (US), Children's Hospital of Philadelphia (US), The Kids Research Institute Australia (AU), Baylor College of Medicine (US), NYU Langone Health (US), Children's Hospital Colorado (US), Mattel Children's Hospital (US), University of Colorado Denver (US)
International Rett Syndrome Foundation, Grace Science Foundation, Ultragenyx Pharmaceutical, Ionis Pharmaceuticals, GW Pharmaceuticals, ACADIA Pharmaceuticals, AveXis, Marinus Pharmaceuticals, LouLou Foundation, International Foundation for CDKL5 Research, Stan Perron Charitable Foundation, National Institutes of Health, National Institute of Neurological Disorders and Stroke
Openalex Percentile: Top 63%
Genetics and Neurodevelopmental Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.